Corporate News     26-Nov-20
Ajanta Pharma announces schedule of activities for proposed buyback
Ajanta Pharma announced the schedule of activities in relation to the Buyback of up to 7.35 lakh equity shares at a price of Rs 1850 per share.

Date of opening of buyback offer - 03 December 2020
Date of closing of buyback offer - 16 December 2020
Last date of receipt of the completed tender forms - 18 December 2020
Last date of settlement of bids on the stock exchange - 24 December 2020

Previous News
  Ajanta Pharma fixes record date for interim dividend
 ( Market Beat - Reports 28-Jul-23   12:34 )
  Ajanta Pharma to convene board meeting
 ( Corporate News - 20-Jan-24   12:12 )
  Ajanta Pharma spurts as Q4 PAT climbs 66% YoY, board OKs Rs 285-cr share buyback
 ( Hot Pursuit - 03-May-24   10:22 )
  Ajanta Pharma hits record high after Q1 PAT rises 19% YoY
 ( Hot Pursuit - 28-Jul-23   10:26 )
  Board of Ajanta Pharma recommends First Interim Dividend
 ( Corporate News - 28-Jul-23   10:22 )
  Ajanta Pharma fixes record date for interim dividend
 ( Market Beat - Reports 03-Nov-22   16:03 )
  Ajanta Pharma
 ( Results - Analysis 01-Feb-23   17:14 )
  Volumes spurt at Galaxy Surfactants Ltd counter
 ( Hot Pursuit - 21-Mar-24   14:30 )
  Volumes soar at Syngene International Ltd counter
 ( Hot Pursuit - 28-Jul-23   11:00 )
  Ajanta Pharma consolidated net profit declines 29.86% in the December 2022 quarter
 ( Results - Announcements 01-Feb-23   16:19 )
  Volumes jump at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 02-Mar-23   14:30 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top